Additional Benefit Scoring During Health Technology Assessment in Germany - Its Drivers and Impact on Pricing and Discount for Orphan Drugs
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.641
https://www.valueinhealthjournal.com/article/S1098-3015(18)32998-X/fulltext
Title :
Additional Benefit Scoring During Health Technology Assessment in Germany - Its Drivers and Impact on Pricing and Discount for Orphan Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32998-X&doi=10.1016/j.jval.2018.07.641
First page :
Section Title :
Open access? :
No
Section Order :
552